Item 1A. Risk Factors

There have been no material changes with respect to risk factors disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides information about the Company’s purchases of its common stock during the quarter ended March 31, 2026:


Period	Total Number of Shares Purchased	Average Price Paid per Share(1)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value that May Yet be Purchased Under the Plans or Programs(2)
January 1, 2026 to January 31, 2026	120,603	$	190.53	120,603	$	901,711,304
February 1, 2026 to February 28, 2026	112,866	208.40		112,866	878,190,219
March 1, 2026 to March 31, 2026	147,696	192.97		147,696	849,689,494
Total	381,165	$	196.77	381,165	$	849,689,494

(1)Excludes commissions and the 1% excise tax imposed by the Inflation Reduction Act of 2022.

(2)On September 17, 2025, the Company’s Board of Directors authorized the repurchase of an additional $635.0 million of the Company’s common shares. This approval is in addition to the prior repurchase authorization of the Company’s Board of Directors of $500.0 million on March 17, 2020. These authorizations have no expiration date and exclude fees, commissions, excise taxes and other expenses related to such common stock repurchases.

Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information